The Company

A Legacy of Innovation

Nanōmix was founded in 2000 by UC Berkeley physics professors Marvin L. Cohen and Alex Zettl as a UC Berkeley spinout to commercialize their proprietary nanotechnology for detecting a wide variety of biological molecules and gases for disease management, industrial process control, and the detection of pollutants in air and water. With private funding from its lead investor Alta Partners (San Francisco) and others, as well as public funding from the U.S. Small Business Administration Innovation Research Program and the Department of Homeland Security, Nanōmix soon achieved a succession of major milestones — including the first large-scale integration of nanotube electronics on a four-inch silicon wafer that forms the basis for the company’s universal detection platform. With $48 million invested, more than 30 patents and 40 additional patents pending, and numerous awards that recognize its innovative technology, today Nanōmix is poised to become the premier provider of analytical detection devices for the next generation of rapid point-of-care (POC) diagnostics in the projected $18 billion global POC market (2012). Based at its 13,000 sq.ft. research and fabrication facility in Emeryville, California, the company is advancing several prototype devices that are ready for partnering opportunities under its collaborative business model.

Partnering with industry leaders for product development and distribution